Canada SynBio 2019 – Pitch Competition

Accelerating Start-ups by Design
Canada SynBio 2019
Pitch Competition Program Overview

Are you a Canadian-based startup company working to commercialize a synbio-based product or service? We want you to apply to pitch for up to $25,000 in prize money in front of leading investors!


Startup companies will be competing for a first prize of $25,000 and second prize of $10,000


  • Startups must be based in Canada and have raised less than $3M in financing
  • Products or services being developed by the company must be based on an engineered biological (synbio) technology
  • Companies must demonstrate access to lab resources required
  • Individuals and students are welcome to apply, but must incorporate as a company if successful in order to receive funds

Program Overview

Application FormStage 1- Submission of written application (January 16th deadline)

  • Startups are invited to submit a written proposal to Ontario Genomics via the application form. Questions cover:
    • The problem you are trying to solve
    • Description of your product or service and differentiation
    • How you are engineering biology and your team’s experience working on this technology
    • Your business plan and estimated timeline to market
    • How the funding will be used

Stage 2- Interview (early February)

  • The top companies based on a pre-screen will be selected for an interview conducted over video conferencing (details on format to be provided to companies selected)
  • The top 6 companies selected from the interview will be invited to pitch in person at the Canada SynBio 2019 conference on March 6th

Stage 3- Mandatory Practice Pitches (mid-February)

  • Teams must present their pitches over video conferencing for feedback

March 6th- Pitch Competition

  • Each company will be given 7 minutes to pitch to a panel of judges consisting of investors who will select the top two companies for awards


  • The funding is offered as a grant, without any ownership stake in the company or any intellectual property being taken by Ontario Genomics or its partners
  • Periodic reporting on the impact of the funding received will be required

For questions please contact Britney Hess, Manager, Investment and Venture Development

Back to 2019 Canada SynBio page

Related Articles